Activity of fluconazole (UK 49,858) and ketoconazole against Candida albicans in vitro and in vivo.
Fluconazole (UK 49,858), a new orally administered bis-triazole, was compared with ketoconazole for activity in synthetic broth dilution susceptibility tests against Candida albicans and also in treatment of experimental systemic candidal infections in rats. In vitro studies indicated that fluconazo...
Na minha lista:
| Udgivet i: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society for Microbiology (ASM)
1986
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC180572/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3022641/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.30.3.418 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|